Key Findings:  Current data suggest a trend towards the benefit of cannabidiol (CBD) and CBD-rich extracts in managing core and behavioral deficits in autism spectrum disorders (ASD) with high safety and tolerability. However, higher-quality placebo-controlled trials should be concluded before considering CBD treatment for ASD.
Type of Study:  Meta-analysis
Study Result:  Inconclusive
Study Location(s):  Israel
Year of Pub:  2024
Cannabinoids Studied:  Cannabidiol (CBD), Pharma CBD
Phytocannabinoid Source:  Unspecified